388 related articles for article (PubMed ID: 18949668)
21. Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis.
Sijssens KM; Rijkers GT; Rothova A; Stilma JS; Schellekens PA; de Boer JH
Exp Eye Res; 2007 Oct; 85(4):443-9. PubMed ID: 17662277
[TBL] [Abstract][Full Text] [Related]
22. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
[TBL] [Abstract][Full Text] [Related]
23. Favorable response to high-dose infliximab for refractory childhood uveitis.
Kahn P; Weiss M; Imundo LF; Levy DM
Ophthalmology; 2006 May; 113(5):860-4.e2. PubMed ID: 16545455
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
25. Pediatric rheumatology for the adult rheumatologist II: uveitis in juvenile idiopathic arthritis.
Wright T; Cron RQ
J Clin Rheumatol; 2007 Aug; 13(4):205-10. PubMed ID: 17762455
[TBL] [Abstract][Full Text] [Related]
26. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis.
Tappeiner C; Roesel M; Heinz C; Michels H; Ganser G; Heiligenhaus A
Eye (Lond); 2009 May; 23(5):1192-8. PubMed ID: 18551142
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis.
Chan AY; Liu DT
J Rheumatol; 2006 Jan; 33(1):198; author reply 198. PubMed ID: 16395772
[No Abstract] [Full Text] [Related]
28. [New treatments for idiopathic juvenile arthritis].
Bader-Meunier B; Quartier P
Arch Pediatr; 2009 Dec; 16(12):1607-11. PubMed ID: 19896351
[TBL] [Abstract][Full Text] [Related]
29. Biologic therapies in juvenile idiopathic arthritis: why and for whom?
McCann LJ; Woo P
Acta Reumatol Port; 2007; 32(1):15-26. PubMed ID: 17450761
[TBL] [Abstract][Full Text] [Related]
30. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
[TBL] [Abstract][Full Text] [Related]
31. [Medical treatment of juvenile idiopathic arthritis].
Kröger L; Vähäsalo P; Tynjälä P; Aalto K; Säilä H; Malin M; Putto-Laurila A; Lahdenne P
Duodecim; 2012; 128(5):477-86. PubMed ID: 22486063
[TBL] [Abstract][Full Text] [Related]
32. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
33. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis.
Kalinina Ayuso V; van de Winkel EL; Rothova A; de Boer JH
Am J Ophthalmol; 2011 Feb; 151(2):217-22. PubMed ID: 21145533
[TBL] [Abstract][Full Text] [Related]
34. Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital.
Petropoulos IK; Vaudaux JD; Guex-Crosier Y
Klin Monbl Augenheilkd; 2008 May; 225(5):457-61. PubMed ID: 18454398
[TBL] [Abstract][Full Text] [Related]
35. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
Borte S; Liebert UG; Borte M; Sack U
Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
[TBL] [Abstract][Full Text] [Related]
37. [Juvenile idiopathic arthritis].
Herlin T
Ugeskr Laeger; 2002 Aug; 164(34):3941-6. PubMed ID: 12212473
[TBL] [Abstract][Full Text] [Related]
38. [Juvenile idiopathic arthritis and uveitis: screening and anti-inflammatory therapy].
Heiligenhaus A; Mingels A; Neudorf U; Ganser G
Klin Monbl Augenheilkd; 2003 Nov; 220(11):738-53. PubMed ID: 14634901
[TBL] [Abstract][Full Text] [Related]
39. [Current therapeutic strategy for rheumatoid arthritis].
Wollenhaupt J; Alten R; Burkhardt H; Edelmann E; Gromnica-Ihle E; Krause A; Krüger K; Manger B; Lorenz H; Müller-Ladner U; Nüsslein H; Pott HG; Tony H; Schneider M
MMW Fortschr Med; 2006 Oct; 148(42):38-42; quiz 43. PubMed ID: 17621798
[TBL] [Abstract][Full Text] [Related]
40. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
Krüger K
MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
